TriStar Health Partners

  • Home
  • About
    • TriStar
    • Team
  • News
  • Investment Strategy
    • Investment Strategy
    • Economic Development Fund – TN Investco
  • Portfolio
  • Contact

Clinical Trial Results Show Synergy between NuSirt Technology and Metformin in Patients with Type 2 Diabetes

February 3, 2016 By tstventures2015

NuSirt Biopharma today announced results from a recently completed clinical trial in patients with type 2 diabetes using its patented technology combining leucine, an essential amino acid, and low doses of metformin. The data from this trial showed comparable improvement in several glucose measures coupled with greater improvement in liver enzymes when comparing a lower dose of metformin in combination with leucine versus full dose metformin. (Read More)

Filed Under: News

Our Portfolio


VIEW MORE

Subscribe to News & Events

Contact Us

Thank you for your interest in TriStar Health Partners. If you have questions or need further information, please contact us!

TriStar Health Partners

3322 West End Ave, Suite 1100 | Nashville, TN 37203
615.515-9880

Copyright © 2023 TriStar Technology Ventures. All rights reserved (CC-licensed photos excepted).